Keen Vision Acquisition Corporation
Status: Live Deal
U=S+W
W=S@11.50
| IPO Proceeds, $M | $149.50M |
|---|---|
| IPO Date | Jul 25, 2023 |
| CEO | Kenneth Ka Chun Wong |
| Left Lead | EF Hutton |
| IPO Cash in Trust | 101.3% |
| SPAC Tenor | 9 + 6 + 9 |
| IPO Sector |
General
Biotechnology, consumer goods, or agriculture, evaluated based on sustainability and environmental, social, and ESG imperatives |
| IPO Geography | Global |
| Target Company | Medera |
| Deal Announced | Sep 5, 2024 |
| Deal Size, $M | $622.60M |
| Deal Sector | Healthcare |
| Deal Geography | US/Canada |
| SEC Filings | www.sec.gov |
| Approval Vote | TBD |
| Amendment Vote | Oct 25, 2024 |
KVAC
KVACU
KVACW
| Price | $10.87 |
|---|---|
| Last closing price | $10.88 |
| H/L, today | $10.87 / $10.88 |
| H/L, 52-week | $10.14 / $10.99 |
| Volume, today | 104,927 |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in for more on Keen Vision Acquisition Corporation:
- Structure and cap table
- 5 directors & officers
- 19 filings and events
- 4 underwriters
- 2 deal advisors
Structure
Sign in to view structure, cap table, and calendar of events.
Team
| Name | Age | Title |
|---|---|---|
| Kenneth Ka Chun Wong | 50 | Chairman and CEO |
| Alex Davidkhanian | 49 | CFO and Director |
| Yibing Peter Ding | 56 | Director |
| William Chu | Director | |
| Albert Cheung-Hoi Yu | 68 | Director |
Sign in to view team biographies and more sponsor and affiliate data.
Advisors
Underwriters
| EF Hutton | Joint BR | 129,040 | units |
| Brookline Capital Markets | Joint BR | 2,500,000 | |
| B. Riley FBR | 10,365,960 | ||
| Westpark Securities | 5,000 | ||
| 13,000,000 | units | ||
| Up-Front UW fee | 2.00 | % | |
| Deferred UW fee |
2.00 | % |
Sign in to view more advisor data.